Literature DB >> 21153230

Selective effects of 8-Br-cAMP on agonists and antagonists of the glucocorticoid receptor.

S Zhang1, M Danielsen.   

Abstract

RU486 has been reported to be a glucocorticoid receptor (GR) and a progesterone receptor (PR) antagonist. We have analysed RU486 activity on the GR in WCL-2 (CHO) cells and in COS-7 cells transiently transfected with the mouse GR and with the reporter MMTVCAT (MCAT). These cell lines do not contain any active progesterone or androgen receptors. In both cell lines RU486 is a partial agonist of the GR with 10-15% of the activity of dexamethasone. As expected, RU486 is also a partial antagonist of the GR. Treatment of COS-7 cells with 8-Br-cAMP increases the agonist activity of both dexamethasone and RU486. This cAMP induced superactivation is seen with all steroids that have full or partial agonist activity. In contrast, the activities of ZK98.299 and R5020, which are complete antagonists of the GR without any agonist activity, are not affected by 8-Br-cAMP treatment. This effect of 8-Br-cAMP is not seen in WCL2 cells. 8-Br-cAMP, therefore, is not a switch which changes antagonists to agonists but is, rather, a cell specific activator of all agonists whether they have full or only partial agonist activity.

Entities:  

Year:  1995        PMID: 21153230     DOI: 10.1007/BF02917442

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

Review 2.  Glucocorticoids and glucocorticoid antagonists: lessons from RU 486.

Authors:  G P Chrousos; L Laue; L K Nieman; S Kawai; R U Udelsman; D D Brandon; D L Loriaux
Journal:  Kidney Int Suppl       Date:  1988-10       Impact factor: 10.545

3.  RU 486.

Authors:  A Ulmann; G Teutsch; D Philibert
Journal:  Sci Am       Date:  1990-06       Impact factor: 2.142

Review 4.  Glucocorticoid antagonists.

Authors:  M K Agarwal; B Hainque; N Moustaid; G Lazer
Journal:  FEBS Lett       Date:  1987-06-15       Impact factor: 4.124

5.  Expression of recombinant androgen receptor in cultured mammalian cells.

Authors:  V E Quarmby; J A Kemppainen; M Sar; D B Lubahn; F S French; E M Wilson
Journal:  Mol Endocrinol       Date:  1990-09

6.  The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates.

Authors:  L Laue; W Gallucci; D L Loriaux; R Udelsman; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

7.  Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells.

Authors:  S S Simons; L Mercier; N R Miller; P A Miller; H Oshima; F D Sistare; E B Thompson; G Wasner; P M Yen
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

8.  Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.

Authors:  C A Sartorius; L Tung; G S Takimoto; K B Horwitz
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

9.  Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density.

Authors:  H Oshima; S S Simons
Journal:  Endocrinology       Date:  1992-04       Impact factor: 4.736

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  2 in total

1.  Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.

Authors:  H Ma; H Hong; S M Huang; R A Irvine; P Webb; P J Kushner; G A Coetzee; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.

Authors:  B L Wagner; J D Norris; T A Knotts; N L Weigel; D P McDonnell
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.